These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 19941413

  • 1. Telomere length and outcome in heart failure.
    van der Harst P, de Boer RA, Samani NJ, Wong LS, Huzen J, Codd V, Hillege HL, Voors AA, van Gilst WH, Jaarsma T, van Veldhuisen DJ.
    Ann Med; 2010; 42(1):36-44. PubMed ID: 19941413
    [Abstract] [Full Text] [Related]

  • 2. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S, Boronat-Garcia M, Albaladejo-Otón MD, Pastor P, Garrido IP, Pastor-Pérez FJ, Martínez-Hernández P, Valdés M, Pascual-Figal DA.
    Am J Cardiol; 2009 Jun 15; 103(12):1753-9. PubMed ID: 19539088
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Telomere length and psychological well-being in patients with chronic heart failure.
    Huzen J, van der Harst P, de Boer RA, Lesman-Leegte I, Voors AA, van Gilst WH, Samani NJ, Jaarsma T, van Veldhuisen DJ.
    Age Ageing; 2010 Mar 15; 39(2):223-7. PubMed ID: 20085922
    [Abstract] [Full Text] [Related]

  • 7. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R.
    J Am Coll Cardiol; 2008 Jul 22; 52(4):266-72. PubMed ID: 18634981
    [Abstract] [Full Text] [Related]

  • 8. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M.
    Circulation; 2007 Jan 16; 115(2):204-12. PubMed ID: 17190867
    [Abstract] [Full Text] [Related]

  • 9. The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure.
    Schou M, Gustafsson F, Corell P, Kistorp CN, Kjaer A, Hildebrandt PR.
    Am Heart J; 2007 Jul 16; 154(1):123-9. PubMed ID: 17584564
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M, Inomata T, Takehana H, Naruke T, Yanagisawa T, Moriguchi M, Takeda S, Izumi T.
    J Am Coll Cardiol; 2008 Jun 17; 51(24):2329-35. PubMed ID: 18549918
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R, Pousset F, Chafirovskaïa O, Carayon A, Hulot JS, Thomas D, Komajda M.
    Am Heart J; 2003 Oct 17; 146(4):729-35. PubMed ID: 14564330
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
    Schou M, Gustafsson F, Kistorp CN, Corell P, Kjaer A, Hildebrandt PR.
    Am J Cardiol; 2007 Nov 15; 100(10):1571-6. PubMed ID: 17996522
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
    Miller WL, Hartman KA, Burritt MF, Grill DE, Rodeheffer RJ, Burnett JC, Jaffe AS.
    Circulation; 2007 Jul 17; 116(3):249-57. PubMed ID: 17592074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.